Guanylate binding protein 5: Impairing virion infectivity by targeting retroviral envelope glycoproteins. (2nd January 2017)

• Record Type: Journal Article
• Authors: Hotter, Dominik; Sauter, Daniel; Kirchhoff, Frank
• Is Part Of: Small GTPases. Volume 8:Number 1(2017)
• Page Start: 31
• Page End: 37
• Publication Date: 2017-01-02
• Subjects: Env -- GBP5 -- HIV-1 -- IFN -- restriction factor -- vpu; Guanosine triphosphatase -- Periodicals; Guanosine triphosphatase; Periodicals; 572.793
• DOI: 10.1080/21541248.2016.1189990
• Languages: English
• ISSNs: 2154-1256

Abstract

ABSTRACT: Guanylate binding proteins (GBPs) are interferon-inducible cellular factors that belong to the superfamily of guanosine triphosphatases (GTPases) and play important roles in the cell-intrinsic defense against bacteria, protozoa and viruses. In a recent report in Cell Host & Microbe, we identify GBP5 as novel restriction factor of HIV-1 that reduces the infectivity of progeny virions by interfering with processing and incorporation of the viral envelope (Env) glycoprotein. The inhibitory activity of GBP5 requires C-terminal isoprenylation, mediating Golgi-association, but not its GTPase function. Notably, GBP5 expression levels vary considerably in human macrophages and inversely correlate with infectious virus yield. We demonstrate that GBP5 can be evaded by an unusual tradeoff mechanism: Naturally occurring mutations in the start codon of the viral accessory gene vpu attenuate GBP5 inhibition by increasing Env expression at the cost of Vpu function. Whether direct counteraction mechanisms or more subtle changes balancing Vpu and Env expression also affect HIV-1 inhibition by GBP5 remains to be clarified. Other open questions are whether GBP5 restricts HIV-1 in CD4 + T cells and if other GBP family members also decrease infectivity of HIV and/or additional enveloped viruses.